Glassman Wealth Services - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Glassman Wealth Services ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,231
-20.0%
920.0%0.00%0.0%
Q2 2023$5,287
+53.2%
920.0%0.00%0.0%
Q1 2023$3,450
+33.8%
920.0%0.00%
Q4 2022$2,578
-14.1%
92
-5.2%
0.00%
-100.0%
Q3 2022$3,000
-25.0%
97
-9.3%
0.00%0.0%
Q2 2022$4,0000.0%107
+9.2%
0.00%0.0%
Q1 2022$4,000
+100.0%
98
+10.1%
0.00%
Q4 2021$2,000
+100.0%
89
+56.1%
0.00%
Q3 2021$1,00057
+375.0%
0.00%
Q2 2021$012
-14.3%
0.00%
Q4 2019$0
-100.0%
14
-72.0%
0.00%
Q3 2019$1,00050
+316.7%
0.00%
Q2 2019$0120.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders